Tag: Amer Zeidan
Trovagene updates on acute myeloid leukemia trial for Onvansertib
Trovagene, a California-based cancer research company, said that it has wrapped up the second dosing cohort of the Onvansertib-decitabine combination, in a phase 1b/2 acute ... Read More